디프테리아 백신 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Diphtheria Vaccine Trends and Forecast

The future of the global diphtheria vaccine market looks promising with opportunities in the hospital, clinic, and vaccination center markets. The global diphtheria vaccine market is expected to reach an estimated $7.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing demand for combination vaccines, rising awareness of the importance of diphtheria vaccination, and growing government initiatives to promote diphtheria vaccination programs.

A more than 150-page report is developed to help in your business decisions.

Diphtheria Vaccine by Segment

The study includes a forecast for the global diphtheria vaccine by vaccine type, end use, and region.

Diphtheria Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

• Dtap Vaccine
• Dt Vaccine
• Tdap Vaccine
• Td Vaccine

Diphtheria Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Vaccination Centers
• Others

Diphtheria Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Diphtheria Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies diphtheria vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the diphtheria vaccine companies profiled in this report include-

• AJ Vaccines
• BIONET
• Glaxosmithkline
• Massbiologics
• Merck & Co
• Panacea Biotech
• Sanofi
• Serum Institute India
• Bharat Biotech
• Meiji

Diphtheria Vaccine Market Insights

Lucintel forecasts that DTaP vaccine will remain the largest segment due to its wide usage to protects against diphtheria, tetanus, and pertussis.

Within this market, hospital will remain the largest segment as it's a common places where people get vaccinated against diphtheria.

North America is expected to witness highest growth over the forecast period due to rising cases of diphtheria among unvaccinated people and presence of key manufacturers in the region.

Features of the Global Diphtheria Vaccine Market

Market Size Estimates: Diphtheria vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Diphtheria vaccine market size by vaccine type, end use, and region in terms of value ($B).

Regional Analysis: Diphtheria vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, end uses, and regions for the diphtheria vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the diphtheria vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the diphtheria vaccine market size?

Answer: The global diphtheria vaccine market is expected to reach an estimated $7.5 billion by 2030.

Q.2 What is the growth forecast for diphtheria vaccine market?

Answer: The global diphtheria vaccine market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the diphtheria vaccine market?

Answer: The major drivers for this market are increasing demand for combination vaccines, rising awareness of the importance of diphtheria vaccination, and growing government initiatives to promote diphtheria vaccination programs.

Q4. What are the major segments for diphtheria vaccine market?

Answer: The future of the diphtheria vaccine market looks promising with opportunities in the hospital, clinic, and vaccination center markets.

Q5. Who are the key diphtheria vaccine market companies?

Answer: Some of the key diphtheria vaccine companies are as follows:

• AJ Vaccines
• BIONET
• Glaxosmithkline
• Massbiologics
• Merck & Co
• Panacea Biotech
• Sanofi
• Serum Institute India
• Bharat Biotech
• Meiji

Q6. Which diphtheria vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that DTaP vaccine will remain the largest segment due to its wide usage to protects against diphtheria, tetanus, and pertussis.

Q7. In diphtheria vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising cases of diphtheria among unvaccinated people and presence of key manufacturers in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the diphtheria vaccine market by vaccine type (DTaP vaccine, DT vaccine, Tdap vaccine, and Td vaccine), end use (hospitals, clinics, vaccination centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Diphtheria Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Diphtheria Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Diphtheria Vaccine Market by Vaccine Type
  • 3.3.1: DTaP Vaccine
  • 3.3.2: DT Vaccine
  • 3.3.3: Tdap vaccine
  • 3.3.4: Td vaccine
• 3.4: Global Diphtheria Vaccine Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Clinics
  • 3.4.3: Vaccination centers
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Diphtheria Vaccine Market by Region
• 4.2: North American Diphtheria Vaccine Market
  • 4.2.2: North American Diphtheria Vaccine Market by End Use: Hospitals, Clinics, Vaccination centers, and Others
• 4.3: European Diphtheria Vaccine Market
  • 4.3.1: European Diphtheria Vaccine Market by Vaccine Type: DTaP Vaccine, DT Vaccine, Tdap vaccine, and Td vaccine
  • 4.3.2: European Diphtheria Vaccine Market by End Use: Hospitals, Clinics, Vaccination centers, and Others
• 4.4: APAC Diphtheria Vaccine Market
  • 4.4.1: APAC Diphtheria Vaccine Market by Vaccine Type: DTaP Vaccine, DT Vaccine, Tdap vaccine, and Td vaccine
  • 4.4.2: APAC Diphtheria Vaccine Market by End Use: Hospitals, Clinics, Vaccination centers, and Others
• 4.5: ROW Diphtheria Vaccine Market
  • 4.5.1: ROW Diphtheria Vaccine Market by Vaccine Type: DTaP Vaccine, DT Vaccine, Tdap vaccine, and Td vaccine
  • 4.5.2: ROW Diphtheria Vaccine Market by End Use: Hospitals, Clinics, Vaccination centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Diphtheria Vaccine Market by Vaccine Type
  • 6.1.2: Growth Opportunities for the Global Diphtheria Vaccine Market by End Use
  • 6.1.3: Growth Opportunities for the Global Diphtheria Vaccine Market by Region
• 6.2: Emerging Trends in the Global Diphtheria Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Diphtheria Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diphtheria Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: AJ Vaccines
• 7.2: BIONET
• 7.3: Glaxosmithkline
• 7.4: MassBiologics
• 7.5: Merck & Co
• 7.6: Panacea Biotech
• 7.7: Sanofi
• 7.8: Serum Institute India
• 7.9: Bharat Biotech
• 7.10: Meiji